Researcher.Life Logo

Vacunas : Impact Factor & More

eISSN: 1578-8857pISSN: 1576-9887

Key Metrics

CiteScore
1.2
SNIP
0.4
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Vacunas

Vacunas Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • SJR SJR
Overview
Publisher Elsevier

Planning to publish in Vacunas ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Vacunas

Trends and burden of malaria in Pakistan and its provinces (1990–2023): Insights from the global burden of disease study
  • 1 Jan 2026
  • Vacunas
Transmission dynamics and evolution of Monkeypox virus (MPXV) during the 2024 global outbreak: implications for surveillance, treatment and vaccination
  • 1 Jan 2026
  • Vacunas
Taming the Marburg threat: lessons from Tanzania’s outbreak response
  • 1 Jan 2026
  • Vacunas
The critical need for broad spectrum vaccines against emerging coronaviruses
  • 1 Jan 2026
  • Vacunas
Developing a novel multi-epitope subunit vaccine to combat monkeypox virus through an immunoinformatics approach
  • 1 Jan 2026
  • Vacunas
Adult contributions to measles transmission in children: Evidence from a two-age model with implications for vaccination strategies in elimination-phase settings
  • 1 Jan 2026
  • Vacunas
Trends and burden of malaria in Pakistan and its provinces (1990–2023): Insights from the global burden of disease study
  • 1 Jan 2026
  • Vacunas
Transmission dynamics and evolution of Monkeypox virus (MPXV) during the 2024 global outbreak: implications for surveillance, treatment and vaccination
  • 1 Jan 2026
  • Vacunas
Taming the Marburg threat: lessons from Tanzania’s outbreak response
  • 1 Jan 2026
  • Vacunas
The critical need for broad spectrum vaccines against emerging coronaviruses
  • 1 Jan 2026
  • Vacunas
Developing a novel multi-epitope subunit vaccine to combat monkeypox virus through an immunoinformatics approach
  • 1 Jan 2026
  • Vacunas
Adult contributions to measles transmission in children: Evidence from a two-age model with implications for vaccination strategies in elimination-phase settings
  • 1 Jan 2026
  • Vacunas

FAQs on Vacunas